Display Settings:

Format

Send to:

Choose Destination
    J Reprod Med. 2008 May;53(5):360-2.

    Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: a case report.

    Source

    Division of Gynecologic Oncology, St. Vincent Hospitals, Indianapolis, Indiana, USA. jgeisler@indianawomensoncology.com

    Abstract

    BACKGROUND:

    Late radiation cystitis is one of the most difficult complications of radiation therapy for pelvic malignancies.

    CASE:

    A 29-year-old woman with a history of cervical cancer presented with radiation-induced hemorrhagic cystitis. The patient received multiple units of packed red blood cells while undergoing several intravesical treatments, including continuous bladder irrigation, 4% formalin, 0.15% AgNO3 and Mg(OH)2 with Al(OH)3. The bleeding finally was stopped by the use of intravenous recombinant factor VIIa.

    CONCLUSION:

    When hemorrhagic cystitis related to late radiation complications is refractory to conventional management, intravenous recombinant factor VIIa may be of benefit.

    PMID:
    18567283
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk